Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06590779

Benefits of a Cosmetic Anti-hair Loss in Males With Hair Loss

Evaluation of the Benefits of a Cosmetic Anti-hair Loss Lotion Applied in Combination With Finasteride in Male Subjects With Hair Loss: Investigator-blinded, Randomized, Multi-center Study Performed Under Dermatological Control

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
140 (estimated)
Sponsor
Cosmetique Active International · Industry
Sex
Male
Age
18 Years – 41 Years
Healthy volunteers
Accepted

Summary

Androgenetic alopecia (AGA), also known as androgenic alopecia or male pattern baldness, is the most common type of progressive hair loss. AGA is a polygenetic condition with varying severity, age of onset, and scalp location of hair loss. In men, hair loss typically involves the temporal and vertex region while sparing the occipital region: the characteristic "horseshoe" pattern. Incidence and prevalence of AGA depend on age and race. Vichy has developed a new cosmetic anti hair loss lotion with the aim of acting on androgenic alopecia. The aim is to improve the efficacy on hair loss of the association of the lotion with finasteride versus finasteride alone. The primary objective of this investigator-blinded, randomized multi-center study is to quantitatively evaluate, using the phototrichogram method, the efficacy of a lotion associated with finasteride versus finasteride alone on hair growth parameters in male subjects with androgenetic alopecia.

Conditions

Interventions

TypeNameDescription
OTHERAminexil® active+ lotionAminexil® active+ lotion
OTHERFinasteride 1mgFinasteride 1 mg

Timeline

Start date
2024-11-02
Primary completion
2025-12-02
Completion
2026-05-02
First posted
2024-09-19
Last updated
2024-09-19

Source: ClinicalTrials.gov record NCT06590779. Inclusion in this directory is not an endorsement.